Compounds > sofosbuvir
Page last updated: 2024-08-25

sofosbuvir and Chronic Illness

sofosbuvir has been researched along with Chronic Illness in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (87.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Lazarus, JV; Lens, S1
Abravanel, F; Akhavan, S; Calmus, Y; Conti, F; Guillemain, R; Lecuyer, L; Marcelin, AG; Mazzola, A; Peytavin, G; Poynard, T; Roque-Afonso, AM; Todesco, E1
Costa, C; D'Ascoli, GL; De Rosa, S; Focà, A; Indolfi, C; Liberto, MC; Mazzitelli, M; Pisani, V; Raffetti, E; Sabatino, J; Strazzulla, A; Torti, C1
Ghosh, R; Lahiri, G; Paul, R; Roy, D; Ruia, AV; Sarkar, R; Sau, TJ1
Chtioui, H; Fraga, M; Gouttenoire, J; Marcu, C; Moradpour, D; Pascual, M; Sahli, R; Vionnet, J1
Gane, E; Hunt, SL; Jacobson, IM; Lawitz, E; Nader, F; Nelson, D; Stepanova, M; Younossi, ZM1
Baroni, GS; Belli, L; Bhoori, S; Burra, P; Cillo, U; De Feo, TM; Donato, F; Fagiuoli, S; Lucà, MG; Marianelli, T; Passigato, N; Picciotto, A; Russo, FP; Spolverato, G; Toniutto, P; Vitale, A1
Dao Thi, VL; Debing, Y; Gouttenoire, J; Moradpour, D; Neyts, J; Rice, CM; Wu, X1

Other Studies

8 other study(ies) available for sofosbuvir and Chronic Illness

ArticleYear
The paediatric population: the forgotten element to eliminating hepatitis C virus.
    The lancet. Gastroenterology & hepatology, 2020, Volume: 5, Issue:4

    Topics: Adolescent; Antiviral Agents; Benzimidazoles; Child; Chronic Disease; Drug Therapy, Combination; Female; Fluorenes; Hepacivirus; Hepatitis C; Humans; Infectious Disease Transmission, Vertical; Liver Diseases; Male; Prevalence; Risk Factors; Sofosbuvir; Uridine Monophosphate; Young Adult

2020
Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective.
    Antiviral therapy, 2018, Volume: 23, Issue:5

    Topics: Antiviral Agents; Cardiomyopathy, Dilated; Chronic Disease; Drug Therapy, Combination; Heart Transplantation; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Ribavirin; Sofosbuvir; Treatment Failure

2018
Evaluation of cardiac function by global longitudinal strain before and after treatment with sofosbuvir-based regimens in HCV infected patients.
    BMC infectious diseases, 2018, Oct-16, Volume: 18, Issue:1

    Topics: Aged; Cardiotoxicity; Chronic Disease; Drug Therapy, Combination; Echocardiography; Female; Heart Function Tests; Hepatitis C; Humans; Longitudinal Studies; Male; Middle Aged; Sofosbuvir; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left

2018
A Patient of Chronic Hepatitis C Complicated by Thalassemia Major and Chronic Osteomyelitis: A Therapeutic Challenge for a Clinician.
    The Journal of the Association of Physicians of India, 2018, Volume: 66, Issue:3

    Topics: Adolescent; Antiviral Agents; beta-Thalassemia; Blood Transfusion; Carbamates; Chronic Disease; Female; Hepatitis C, Chronic; Humans; Imidazoles; Osteomyelitis; Pyrrolidines; Sofosbuvir; Valine

2018
Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report.
    BMC gastroenterology, 2019, May-24, Volume: 19, Issue:1

    Topics: Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Hepatitis E; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Postoperative Period; Ribavirin; Sofosbuvir

2019
Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens.
    Hepatology (Baltimore, Md.), 2014, Volume: 59, Issue:6

    Topics: Adult; Antiviral Agents; Chronic Disease; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Retrospective Studies; Ribavirin; Sofosbuvir; Treatment Outcome; Uridine Monophosphate

2014
Cost-effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantation.
    Transplant international : official journal of the European Society for Organ Transplantation, 2015, Volume: 28, Issue:9

    Topics: Antiviral Agents; Chronic Disease; Cost-Benefit Analysis; End Stage Liver Disease; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Italy; Kaplan-Meier Estimate; Liver Failure; Liver Transplantation; Male; Markov Chains; Middle Aged; Preoperative Period; Probability; Recurrence; Research Design; Retrospective Studies; Sofosbuvir; Treatment Outcome; Waiting Lists

2015
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin.
    Gastroenterology, 2016, Volume: 150, Issue:1

    Topics: Antiviral Agents; Chronic Disease; Drug Synergism; Drug Therapy, Combination; Hepatitis E; Hepatitis E virus; Humans; In Vitro Techniques; Ribavirin; RNA, Viral; Sofosbuvir; Virus Replication

2016